Table 3.
ANOVA analyses of CD4+ HLA-G+ T lymphocytes.
| Model | Groups | Mean difference (95% CI) | SMD (95% CI) | Partial Eta2 | P value$ |
|---|---|---|---|---|---|
| Crude | Critical vs Moderate/Severe | −1.77 (−2.72; −0.82) | −1.27 (−1.86; −0.66) | 0.222 | 0.0001 |
| Critical vs Healthy control | −0.97 (−1.92; −0.01) | −0.69 (−1.25; −0.12) | – | – | |
| Moderate/Severe vs Healthy control | 0.80 (−0.15; 1.76) | 0.57 (0.01; 1.13) | – | – | |
| Adjusted for age | Critical vs Moderate/Severe | −1.81 (−2.79; −0.83) | −1.25 (−1.84; −0.65) | 0.222 | 0.0003 |
| Critical vs Healthy control | −0.92 (−1.97; 0.11) | −0.63 (−1.19; −0.06) | – | – | |
| Moderate/Severe vs Healthy control | 0.88 (−0.11; 1.88) | 0.60 (0.04; 1.16) | – | – | |
| Adjusted for gender | Critical vs Moderate/Severe | −1.89 (−2.85; −0.93) | −1.34 (−1.94; −0.73) | 0.248 | 0.0001 |
| Critical vs Healthy control | −1.11 (−2.09; −0.13) | −0.79 (−1.35; −0.21) | – | – | |
| Moderate/Severe vs Healthy control | 0.78 (−0.18; 1.75) | 0.55 (−0.006; 1.11) | – | – |